Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.110
+0.100 (2.49%)
May 6, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $240.52 million as of May 6, 2026. Its market cap has increased by 121.05% in one year.
Market Cap
240.52M
Enterprise Value
149.96M
1-Year Change
121.05%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $240.52M, an increase of 21.82%. That is a compound annual growth rate of 3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 234.67M | 0.15% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 245.17M |
| Codexis | 243.53M |
| Achieve Life Sciences | 242.77M |
| Milestone Pharmaceuticals | 236.71M |
| Voyager Therapeutics | 236.61M |
| Fennec Pharmaceuticals | 234.60M |
| Adagene | 231.91M |
| Keros Therapeutics | 231.32M |